-
Je něco špatně v tomto záznamu ?
Investigation of potential ascorbate peroxidase inhibitors for anti-leishmaniasis therapy
AA. Rabaan, MA. Alshahrani, B. Othman, M. Alfaresi, YA. Almutawif, HMA. Eid, A. Saif, AA. Alshehri
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
- MeSH
- antiprotozoální látky * farmakologie chemie MeSH
- inhibitory enzymů * farmakologie chemie MeSH
- kvantitativní vztahy mezi strukturou a aktivitou MeSH
- leishmanióza * farmakoterapie MeSH
- lidé MeSH
- simulace molekulového dockingu MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
L eishmaniasis is a prevalent disease that impacts 98 countries and territories, mainly in Africa, Asia, and South America. It can cause substantial illness and death, particularly in its visceral manifestation that can be specifically targeted in the development of medications to combat leishmaniasis. This study has found natural compounds with possible inhibitory activity against APX using a reliable and accurate QSAR model. Despite the severe side effects of current treatments and the absence of an effective vaccination, these compounds show promise as a potential treatment for the disease. Nine hit compounds were found, and subsequent molecular docking was performed. Estradiol cypionate showed the lowest binding energy (- 10.5 kcal/mol), thus showing the strongest binding, and also had the strongest binding affinity, with a ΔGTotal of - 26.31 ± 3.01 kcal/mol, second only to the control molecule. Additionally, three hits viz. cloxacillin-sodium (- 16.57 ± 2.89 kcal/mol), cinchonidine (- 16.04 ± 3.27 kcal/mol), and quinine hydrochloride dihydrate (13.38 ± 1.06 kcal/mol) also showed significant binding affinity. Multiple interactions between drugs and active site residues demonstrated a substantial binding affinity with the target protein. The identified compounds exhibited drug-like effects and were orally bioavailable based on their ADME-toxicology features. Overall, estradiol cypionate, cloxacillin sodium, cinchonidine, and quinine hydrochloride dihydrate all exhibited inhibitory effects on the APX enzyme of Leishmania donovani. These results suggest that further investigation is needed to explore the potential of developing novel anti-leishmaniasis drugs using these compounds.
College of Medicine Alfaisal University Riyadh Saudi Arabia 11 533
Department of Public Health and Nutrition The University of Haripur Haripur Pakistan 22 610
Molecular Diagnostic Laboratory Johns Hopkins Aramco Healthcare 31 311 Dhahran Saudi Arabia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25013017
- 003
- CZ-PrNML
- 005
- 20250605092910.0
- 007
- ta
- 008
- 250605s2025 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12223-024-01190-z $2 doi
- 035 __
- $a (PubMed)39153157
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Rabaan, Ali A $u Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, 31,311, Dhahran, Saudi Arabia. arabaan@gmail.com $u College of Medicine, Alfaisal University, Riyadh, Saudi Arabia, 11,533. arabaan@gmail.com $u Department of Public Health and Nutrition, The University of Haripur, Haripur, Pakistan, 22,610. arabaan@gmail.com $1 https://orcid.org/0000000267749847
- 245 10
- $a Investigation of potential ascorbate peroxidase inhibitors for anti-leishmaniasis therapy / $c AA. Rabaan, MA. Alshahrani, B. Othman, M. Alfaresi, YA. Almutawif, HMA. Eid, A. Saif, AA. Alshehri
- 520 9_
- $a L eishmaniasis is a prevalent disease that impacts 98 countries and territories, mainly in Africa, Asia, and South America. It can cause substantial illness and death, particularly in its visceral manifestation that can be specifically targeted in the development of medications to combat leishmaniasis. This study has found natural compounds with possible inhibitory activity against APX using a reliable and accurate QSAR model. Despite the severe side effects of current treatments and the absence of an effective vaccination, these compounds show promise as a potential treatment for the disease. Nine hit compounds were found, and subsequent molecular docking was performed. Estradiol cypionate showed the lowest binding energy (- 10.5 kcal/mol), thus showing the strongest binding, and also had the strongest binding affinity, with a ΔGTotal of - 26.31 ± 3.01 kcal/mol, second only to the control molecule. Additionally, three hits viz. cloxacillin-sodium (- 16.57 ± 2.89 kcal/mol), cinchonidine (- 16.04 ± 3.27 kcal/mol), and quinine hydrochloride dihydrate (13.38 ± 1.06 kcal/mol) also showed significant binding affinity. Multiple interactions between drugs and active site residues demonstrated a substantial binding affinity with the target protein. The identified compounds exhibited drug-like effects and were orally bioavailable based on their ADME-toxicology features. Overall, estradiol cypionate, cloxacillin sodium, cinchonidine, and quinine hydrochloride dihydrate all exhibited inhibitory effects on the APX enzyme of Leishmania donovani. These results suggest that further investigation is needed to explore the potential of developing novel anti-leishmaniasis drugs using these compounds.
- 650 _2
- $a simulace molekulového dockingu $7 D062105
- 650 12
- $a antiprotozoální látky $x farmakologie $x chemie $7 D000981
- 650 12
- $a inhibitory enzymů $x farmakologie $x chemie $7 D004791
- 650 _2
- $a kvantitativní vztahy mezi strukturou a aktivitou $7 D021281
- 650 12
- $a leishmanióza $x farmakoterapie $7 D007896
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a lidé $7 D006801
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Alshahrani, Mohammed Abdulrahman $u Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Najran University, Najran, Saudi Arabia, 61,441
- 700 1_
- $a Othman, Basim $u Department of Public Health, Faculty of Applied Medical Sciences,, Albaha University, Albaha, Saudi Arabia, 65,77
- 700 1_
- $a Alfaresi, Mubarak $u Department of Microbiology, National Reference Laboratory, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates, 92,323 $u Department of Pathology, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates, 505,055
- 700 1_
- $a Almutawif, Yahya A $u Department of Medical Laboratories Technology, College of Applied Medical Sciences, Taibah University, Madinah, Saudi Arabia, 41,411
- 700 1_
- $a Eid, Hamza M A $u Department of Medical Laboratories Technology, College of Applied Medical Sciences, Taibah University, Madinah, Saudi Arabia, 41,411
- 700 1_
- $a Saif, Ahmed $u Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia, 62,223
- 700 1_
- $a Alshehri, Ahmad A $u Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Najran University, Najran, Saudi Arabia, 61,441. aaalshehri@nu.edu.sa
- 773 0_
- $w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 70, č. 2 (2025), s. 371-390
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39153157 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250605 $b ABA008
- 991 __
- $a 20250605092904 $b ABA008
- 999 __
- $a ok $b bmc $g 2333594 $s 1250127
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 70 $c 2 $d 371-390 $e 20240817 $i 1874-9356 $m Folia microbiologica $n Folia Microbiol (Praha) $x MED00011005
- LZP __
- $a Pubmed-20250605